Back

Governance

The Human Cell Atlas comprises members from many scientific institutions around the world. It is only by working together that we will be able to achieve the ambitious goals of this project.

The HCA is steered and governed by an Organizing Committee (OC), which is the decision-making body of the HCA. The OC is co-chaired by Aviv Regev and Sarah Teichmann.

The OC has an Executive Committee (EC) that is responsible for performing routine tasks between OC meetings, reviewing meeting agendas, and providing guidance to the HCA Executive Office.

Committee Members

Ido Amit

Weizmann Institute of Science, Israel

Fabiana Arzuaga

University of Buenos Aires, Argentina

Gary Bader

University of Toronto, Canada

Christoph Bock

CeMM, Austria

Piero Carninci

Fondazione Human Technopole, Italy & RIKEN, Japan

Hans Clevers

Hubrecht Institute, The Netherlands

Roland Eils

Berlin Institute of Health – Charité Universitätsmedizin Berlin, Germany

Nir Hacohen

Broad Institute, USA

Muzlifah Haniffa

Wellcome Sanger Institute/Newcastle University, UK

Bartha Knoppers

McGill University, Canada

Mark Krasnow

Stanford University, USA

Arnold Kriegstein

University of California, San Francisco, USA

Ed Lein

Allen Institute, USA

Sten Linnarsson

Karolinska Institutet, Sweden

Partha Majumder

John C. Martin Centre for Liver Research & Innovations and Liver Foundation, West Bengal, India

John Marioni

Genentech, South San Francisco, CA, USA; EMBL-EBI, Cambridge, UK; CRUK Cambridge Institute, University of Cambridge, Cambridge, UK

Miriam Merad

Mount Sinai, USA

Musa M Mhlanga

Radboud University, The Netherlands

Shalin Naik

Walter + Eliza Hall Institute of Medical Research, Australia

Garry Nolan

Stanford University, USA

Dana Pe'er

Memorial Sloan Kettering Cancer Institute, USA

Shyam Prabhakar

Genome Institute of Singapore, Singapore

Nikolaus Rajewsky

Helmholtz Association, Germany

Aviv Regev

Genentech, USA

Patricia Severino

Albert Einstein Research and Education Institute, Brazil

Jay Shin

Genomic Institute of Singapore, A*STAR, Singapore and RIKEN, Japan

Henk Stunnenberg

Prinses Maxima Centrum, The Netherlands

Sarah Teichmann

Wellcome Cambridge Stem Cell Institute

Fabian Theis

Helmholtz-Munich, Germany

Chloe Villani

Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA

Jonathan Weissman

Massachusetts Institute of Technology, USA

Christine Wells

University of Melbourne, Australia

Barbara Wold

Caltech, USA

Xiaowei Zhuang

Howard Hughes Medical Institute, USA and Harvard University, USA

Alexander van Oudenaarden

Hubrecht Institute, The Netherlands

Alumni (OC)

Peter Campbell, (2017-2019)

Wellcome Sanger Institute, UK

Eric Lander, (2017-2021)

Broad Institute, USA

Chris Ponting, (2017-2019)

Edinburgh University, UK

Steve Quake (2017-2022)

Stanford University / CZ Biohub, USA

Ehud Shapiro, (2017-2019)

Weizmann Institute, Israel

Michael Stratton, (2017-2022)

Wellcome Sanger Institute, UK

Organising Committee (OC)

Ayah Al-Rawni

UK office

Yoshi Ando

Asia office

Gary Bader

University of Toronto, Canada

Piero Carninci

Fondazione Human Technopole, Italy & RIKEN, Japan

Esther Chua

Singapore office

Muzlifah Haniffa

Wellcome Sanger Institute/Newcastle University, UK

Bridget O'Donnell

USA office

Shyam Prabhakar

Genome Institute of Singapore, Singapore

John Randell

USA office

Aviv Regev

Genentech, USA

Lucia Robson

UK office

Kristine Schwenk

USA office

Sarah Teichmann

Wellcome Cambridge Stem Cell Institute

Ellen Todres

USA office

Chloe Villani

Massachusetts General Hospital, Harvard Medical School and Broad Institute, USA

Samantha Wynne

UK office

Executive Committee (EC)